標(biāo)題: Titlebook: Beta-Blockers in the Elderly; Erich Lang,Fritz S?rgel,Lothar Blaha Conference proceedings 1982 Springer-Verlag Berlin Heidelberg 1982 Alte [打印本頁(yè)] 作者: 照相機(jī) 時(shí)間: 2025-3-21 19:46
書目名稱Beta-Blockers in the Elderly影響因子(影響力)
書目名稱Beta-Blockers in the Elderly影響因子(影響力)學(xué)科排名
書目名稱Beta-Blockers in the Elderly網(wǎng)絡(luò)公開度
書目名稱Beta-Blockers in the Elderly網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Beta-Blockers in the Elderly被引頻次
書目名稱Beta-Blockers in the Elderly被引頻次學(xué)科排名
書目名稱Beta-Blockers in the Elderly年度引用
書目名稱Beta-Blockers in the Elderly年度引用學(xué)科排名
書目名稱Beta-Blockers in the Elderly讀者反饋
書目名稱Beta-Blockers in the Elderly讀者反饋學(xué)科排名
作者: 充滿裝飾 時(shí)間: 2025-3-21 22:38
ernational symposium on "Beta- Blockers in the Elderly." It was the intention of the Scientific Committee that during this symposium we would discuss the specific problems and therapeutic implications arising when elderly people have to be treated with beta-blocking agents. Special emphasis was plac作者: 向宇宙 時(shí)間: 2025-3-22 00:49
Agnès Labrousse,Jean-Daniel Weiszon into β. and β.. Table 1 shows some adrenergic effects and the type of receptor mainly involved in mediating each effect. α-Receptors mediate, for instance, contraction of smooth muscle in blood vessels and uterus, while β.-receptors mediate cardiac stimulation and other effects such as lipolysis and release of renin.作者: 溫和女人 時(shí)間: 2025-3-22 08:17 作者: 向下五度才偏 時(shí)間: 2025-3-22 12:30
β-Blockers: Theory, Action, and Application to the Elderlyon into β. and β.. Table 1 shows some adrenergic effects and the type of receptor mainly involved in mediating each effect. α-Receptors mediate, for instance, contraction of smooth muscle in blood vessels and uterus, while β.-receptors mediate cardiac stimulation and other effects such as lipolysis and release of renin.作者: DRAFT 時(shí)間: 2025-3-22 14:05
Secondary Prevention Trials with β-Blocking Drugs After Myocardial Infarctionive trials have been planned and carried out. The purpose of the present paper is to review the published findings. Special attention will be paid to the major points of criticism often raised in connection with the respective trials, in an effort to prepare a rationale for our clinical management of patients today.作者: 注射器 時(shí)間: 2025-3-22 20:03 作者: endoscopy 時(shí)間: 2025-3-23 00:55 作者: 尖酸一點(diǎn) 時(shí)間: 2025-3-23 04:51
Treatment of Hypertension with β-Blockers in Elderly Patientsrated beyond doubt by numerous studies in Western countries that blood pressure increases with age. Therefore, the WHO definition of hypertension is especially inappropriate for defining hypertension in the elderly.作者: outrage 時(shí)間: 2025-3-23 06:03 作者: flimsy 時(shí)間: 2025-3-23 10:23 作者: 套索 時(shí)間: 2025-3-23 15:54 作者: 分期付款 時(shí)間: 2025-3-23 20:40 作者: Vo2-Max 時(shí)間: 2025-3-23 22:19
Agnès Labrousse,Jean-Daniel Weisztwo kinds of receptors: α and β. More recent studies have shown that β-adrenoceptors are not homogeneous. Lands et al. [18] have suggested a subdivision into β. and β.. Table 1 shows some adrenergic effects and the type of receptor mainly involved in mediating each effect. α-Receptors mediate, for i作者: 材料等 時(shí)間: 2025-3-24 02:57 作者: Pepsin 時(shí)間: 2025-3-24 09:31 作者: staging 時(shí)間: 2025-3-24 11:42
https://doi.org/10.1007/978-3-319-70350-3in circulating plasma noradrenaline levels [2], which may compensate for reduced receptor sensitivity, and this increased level of plasma noradrenaline might compete with isoprenaline or propranolol for beta-receptor binding in the heart [3].作者: bronchodilator 時(shí)間: 2025-3-24 16:32 作者: Commission 時(shí)間: 2025-3-24 19:08
Michal Neubauer-Shani,Omri Shamir treated with β-blockers [1–5]. However, these trials are all exposed to the drawbacks and dangers of retrospective observations. A number of prospective trials have been planned and carried out. The purpose of the present paper is to review the published findings. Special attention will be paid to 作者: FILLY 時(shí)間: 2025-3-24 23:48
https://doi.org/10.1057/97811374463507]. This is particularly true with regard to carbohydrate and fat metabolism. In metabolic fields, catecholamines exert their action via β.- and/or β.-receptors, whereas the sympathetic influence on the heart is mainly mediated by β.-receptors [37].作者: Restenosis 時(shí)間: 2025-3-25 04:12 作者: PHAG 時(shí)間: 2025-3-25 10:37 作者: myocardium 時(shí)間: 2025-3-25 13:36 作者: creditor 時(shí)間: 2025-3-25 19:18 作者: 連系 時(shí)間: 2025-3-25 21:54
β-Receptor Therapy of Cardiac Rhythm Disturbances in Old AgeCardiac rhythm disturbances in the form of disturbances in impulse formation and in conductivity increase in old age. Impaired myocardial capacity in connection with cardiac rhythm disturbances generally produces the clinical picture of cardiac insufficiency.作者: malapropism 時(shí)間: 2025-3-26 03:10
Problems of Physical Activity During Treatment with β-BlockersThe question of physical activity during treatment with β-blockers raises a couple of interesting problems, especially from the viewpoint of older people. Physical training today is very often undertaken by old people, who might also be under treatment by β-blockers.作者: 流動(dòng)性 時(shí)間: 2025-3-26 08:17 作者: anthropologist 時(shí)間: 2025-3-26 12:15 作者: 定點(diǎn) 時(shí)間: 2025-3-26 15:13 作者: Projection 時(shí)間: 2025-3-26 17:29
Kameliia Petrova,Agnitra RoyChoudhuryum was devoted to them at the last world congress of psychiatry (Kielholz 1978). During the past years some of the indications tested were based on clinical results, while others emerged from rather experimental investigations. They can be divided into four major clinical areas, and are discussed in the order of their practical importance.作者: 泰然自若 時(shí)間: 2025-3-26 22:30
Pharmacokinetics of β-Blockers in the Elderlyparameters. These parameters include the liberation of the drug from its formulation, its absorption from the site of application, its distribution within the body, and its elimination via metabolism and excretion, and thus determine how the drug gets access to its target organs.作者: antenna 時(shí)間: 2025-3-27 03:31 作者: 較早 時(shí)間: 2025-3-27 09:04
Metabolic Effects of β-Blockers7]. This is particularly true with regard to carbohydrate and fat metabolism. In metabolic fields, catecholamines exert their action via β.- and/or β.-receptors, whereas the sympathetic influence on the heart is mainly mediated by β.-receptors [37].作者: Enrage 時(shí)間: 2025-3-27 11:52 作者: MANIA 時(shí)間: 2025-3-27 14:08
β-Blockers: Theory, Action, and Application to the Elderlytwo kinds of receptors: α and β. More recent studies have shown that β-adrenoceptors are not homogeneous. Lands et al. [18] have suggested a subdivision into β. and β.. Table 1 shows some adrenergic effects and the type of receptor mainly involved in mediating each effect. α-Receptors mediate, for i作者: 褪色 時(shí)間: 2025-3-27 18:34 作者: 省略 時(shí)間: 2025-3-27 22:38
Treatment of Hypertension with β-Blockers in Elderly Patientso be defined: “hypertension” and “elderly”. There are numerous definitions of hypertension in the literature, which only illustrates the fact that the division between normotension and hypertension is an artificial one. Probably the most widely used definition is the one given by the World Health Or作者: SPER 時(shí)間: 2025-3-28 02:37 作者: APEX 時(shí)間: 2025-3-28 07:34
Treatment of Myocardial Infarction with β-Blockers in Elderly Patientsearly mortality. The introduction of special coronary care units in the 1960s has reduced hospital mortality by almost 50% (e. g., Hofvendahl 1971). A number of studies during the past 15 years have shown that both the immediate and long-term prognoses after acute myocardial infarction are very much作者: 夸張 時(shí)間: 2025-3-28 11:56 作者: 不滿分子 時(shí)間: 2025-3-28 14:47
Metabolic Effects of β-Blockers7]. This is particularly true with regard to carbohydrate and fat metabolism. In metabolic fields, catecholamines exert their action via β.- and/or β.-receptors, whereas the sympathetic influence on the heart is mainly mediated by β.-receptors [37].作者: 格子架 時(shí)間: 2025-3-28 21:53 作者: Negotiate 時(shí)間: 2025-3-28 23:31
Indications for β-Blockers in Glaucoma Patientsdrug system for glaucoma therapy [1–6]. Within a very few years, the acceptance of β-blockers by glaucoma patients turned out to be better than that of other drug system. Before the introduction of the β-blockers, miotics and epinephrine dominated glaucoma therapy. Since β-blockers lack the visual a作者: 使困惑 時(shí)間: 2025-3-29 06:07 作者: milligram 時(shí)間: 2025-3-29 07:46 作者: 引導(dǎo) 時(shí)間: 2025-3-29 12:05
